IP Library Granted Patent US 8,211,652
Granted Patent B2
US 8,211,652 · App. 12/864,709 · Granted Jul 3, 2012

FSTL-1 as a biomaker of inflammation

Assignee: University of Pittsburgh—of the Commonwealth System of Higher Education
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,211,652
App. No.
12/864,709
Granted
Jul 3, 2012
Kind
B2
Abstract

The invention provides methods and kits for diagnosing severity of particular types of inflammatory diseases, such as rheumatic diseases, by assessing protein levels of follistatin-like protein 1 (FSTL-1). The level of FSTL-1 protein present in the serum or synovial fluid of individuals suspected of having certain inflammatory disease (e.g, rheumatoid arthritis) is positively correlated with the severity of the disease.

Claims (4)

1. A method for diagnosing systemic juvenile rheumatoid arthritis in an individual comprising: (a) measuring the level of protein expression of follistatin-like protein-1 in a biological sample collected from the individual; and (b) comparing the level of protein expression of follistatin-like protein-1 in the sample from the individual with the level of follistatin-like protein 1 in a healthy subject, where an increased level of follistatin-like protein-1 in the individual sample relative to the healthy subject, wherein the individual exhibits joint swelling, indicates that the individual has a diagnosis of systemic juvenile rheumatoid arthritis.

2. A method for diagnosing Kawasaki's disease in an individual comprising: (a) measuring the level of protein expression of follistatin-like protein-1 in a biological sample collected from the individual; and (b) comparing the level of protein expression of follistatin-like protein-1 in the sample from the individual with the level of follistatin-like protein 1 in a healthy subject, where an increased level of follistatin-like protein-1 in the individual sample relative to the healthy subject, wherein the individual exhibits one or more symptom selected from the group consisting of eye redness, rash on stomach, chest and genitals, red and dry lips, swollen tongue, coated tongue, sore throat, swollen palms, swollen soles of feet, swollen lymph nodes, and combinations thereof, indicates that the individual has a diagnosis of Kawasaki's disease.

3. The method according to claim 1 wherein the level of follistatin-like protein-1 is measured by enzyme linked immunosorbent assay.

4. The method according to claim 2 wherein the level of follistatin-like protein-1 is measured by enzyme linked immunosorbent assay.

Assignments (2)
CONFIRMATORY LICENSE Recorded Oct 19, 2011
From: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027083/0681 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2010
From: HIRSCH, RAPHAEL
To: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Reel/Frame 025226/0821 →
Continuity (2)
Provisional Application 61024487 · Jan 29, 2008
Related Publication 20110045507A1 · Feb 24, 2011